In Silico Evaluation of the Biopharmaceutical and Pharmacokinetic Behavior of Metronidazole from Coated Colonic Release Matrix Tablets
Pharmaceutics · 14.05.2025 · 17 (5) · 647
DOI: 10.3390/pharmaceutics17050647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 14.05.2025. Verfasst von Roberto Arévalo-Pérez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Physiologically based biopharmaceutics modeling (PBBM) models can help to predict drug release and in vivo absorption behaviors. Colon drug delivery systems have gained interest over the past few years due to the advantages they provide in treating certain diseases in a local way. The objectives of this work were to simulate the biopharmaceutical and pharmacokinetic behavior of metronidazole hydrophilic matrices coated with different enteric polymers and to highlight the factors with a significant impact on the simulated pharmacokinetic parameters.
Methods
Physicochemical properties of metronidazole were introduced into Simcyp® simulator platform, and the Advanced Dissolution Absorption Model (ADAM) was employed to simulate the in vivo intestinal absorption and colonic concentrations of metronidazole using a PBBM model. A Kruskal–Wallis test was carried out in order to determine which one of the factors studied has a statistically significant impact on the pharmacokinetic parameters (AUC, Cmax, and Tmax) simulated.
Results
Enteric-coated matrix tablets are capable of avoiding metronidazole absorption in the small intestine and releasing it in the colonic region. The release and absorption rates of metronidazole depend largely on the percentage of weight gain of the coating and also on the coating agent. Coated tablets with a time-dependent coating show less variability.
Conclusions
PBBM models can help predict the release from drug delivery systems and the pharmacokinetics in vivo of metronidazole from data obtained in vitro, although complementary in vivo studies should be needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.
- Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
ORCID-Profile: Cristina Maderuelo, José M Lanao
Zitieren
APA
Arévalo-Pérez, R., Maderuelo, C., & Lanao, J. M. (2025). In Silico Evaluation of the Biopharmaceutical and Pharmacokinetic Behavior of Metronidazole from Coated Colonic Release Matrix Tablets. Pharmaceutics, 17(5), 647. https://doi.org/10.3390/pharmaceutics17050647
Vancouver
Arévalo-Pérez R, Maderuelo C, Lanao JM. In Silico Evaluation of the Biopharmaceutical and Pharmacokinetic Behavior of Metronidazole from Coated Colonic Release Matrix Tablets. Pharmaceutics. 2025;17(5):647. doi:10.3390/pharmaceutics17050647
BibTeX
@article{ArvaloPrez2025,
author = {Arévalo-Pérez, Roberto and Maderuelo, Cristina and Lanao, José M},
title = {In Silico Evaluation of the Biopharmaceutical and Pharmacokinetic Behavior of Metronidazole from Coated Colonic Release Matrix Tablets},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {5},
pages = {647},
doi = {10.3390/pharmaceutics17050647}
}
EUVIMED